Literature DB >> 24923479

MRI appearances of ovarian serous borderline tumor: pathological correlation.

Shu Hui Zhao1, Jin Wei Qiang, Guo Fu Zhang, Orest B Boyko, Shi Jia Wang, Song Qi Cai, Li Wang.   

Abstract

PURPOSE: To investigate the spectrum of MRI appearances of ovarian serous borderline tumor (SBT).
MATERIALS AND METHODS: Following ethics approval, 31 patients with 51 histologically proven ovarian SBTs underwent preoperative MRI. Images were evaluated, by two observers for the location, shape, size, internal architecture, signal intensity, and extent or stage of the tumors. The MRI findings were correlated with pathological findings.
RESULTS: Twenty of 31 patients (65%) demonstrated bilateral ovarian SBTs on MRI. Three MRI morphological patterns of ovarian SBT were identified: (i) Mainly cystic mass with multiple intracystic papillary projections from the wall and septations was observed in 24 (47%) tumors. (ii) Solid mass with hierarchical branching papillary and fibrous stalk architecture was observed in 8 (16%) tumors. The branching papillary projections were hyperintensity on T2WI, intermediate intense on DWI, and enhanced intensely after the administration of Gd-DTPA. The internal branching fibrous stalks were hypointensity on T2WI and enhanced slightly. (iii) Mixed cystic-solid mass was observed in 19 (37%) tumors. The cystic and solid components had the architecture and signal intensity similar to those of cystic and solid SBTs. Papillary projections were the common architecture of all three types of tumors.
CONCLUSION: On MRI, the ovarian SBT has some morphological distinguishing features. The solid papillary architecture with internal branching fibrous stalk is a somewhat more characteristic MRI appearance.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  MRI; borderline; ovary; serous

Mesh:

Year:  2013        PMID: 24923479     DOI: 10.1002/jmri.24339

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation.

Authors:  Sung Bin Park; Min-Jeong Kim; Kyoung Ho Lee; Yousun Ko
Journal:  Br J Radiol       Date:  2018-06-21       Impact factor: 3.039

Review 2.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

3.  MRI for discriminating metastatic ovarian tumors from primary epithelial ovarian cancers.

Authors:  Yanhong Xu; Jia Yang; Zaixian Zhang; Guixiang Zhang
Journal:  J Ovarian Res       Date:  2015-08-28       Impact factor: 4.234

4.  MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.

Authors:  Go Nakai; Takashi Yamada; Kazuhiro Yamamoto; Yoshinobu Hirose; Masahide Ohmichi; Yoshifumi Narumi
Journal:  J Ovarian Res       Date:  2018-01-10       Impact factor: 4.234

5.  Spontaneously Ruptured Paraovarian Tumor of Borderline Malignancy with Extremely Elevated Serum Carbohydrate Antigen 125 (CA125) Levels: A Comparison of the Imaging and Pathological Features.

Authors:  Akiko Kajiyama; Hiromi Edo; Chiaki Takeya; Kaneyuki Kubushiro; Toshiaki Oharaseki; Tatsuya Gomi
Journal:  Am J Case Rep       Date:  2017-08-24

Review 6.  Serous borderline ovarian tumours: an extensive review on MR imaging features.

Authors:  Hilal Sahin; Asli Irmak Akdogan; Janette Smith; Jeries Paolo Zawaideh; Helen Addley
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

7.  Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.

Authors:  Yasuhisa Kurata; Aki Kido; Yusaku Moribata; Kyoko Kameyama; Sachiko Minamiguchi; Ikuo Konishi; Kaori Togashi
Journal:  Magn Reson Med Sci       Date:  2017-10-06       Impact factor: 2.471

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.